NOT-AI-02-005: NIAID SMALL BUSINESS PROGRAM ON BIOTERRORISM-RELATED RESEARCH (SB-BTRR)

Department of Health
and Human Services (HHS)
NIH... Turning Discovery Into Health^®

NIAID SMALL BUSINESS PROGRAM ON BIOTERRORISM-RELATED RESEARCH (SB-BTRR)

Release Date:  November 26, 2001

NOTICE:  NOT-AI-02-005

Receipt Date:  January 23, 2002

National Institute of Allergy and Infectious Diseases (NIAID)
 (http://www.niaid.nih.gov)

NIAID announces an amendment to the NIH Omnibus Solicitation for Small 
Business Innovation Research(SBIR) and Small Business Technology 
Transfer (STTR) Grant Applications 
(http://grants.nih.gov/grants/funding/sbirsttr1/index.pdf) to encourage 
SBIR and STTR grants on Bioterrorism-Related Research (SB-BTRR). The 
purpose of this program is to fund SBIR and STTR grants focused on 
organisms that may be used in bioterrorism activities. All other 
requirements and instructions for NIH SBIR and STTR applications apply. 
The January 23, 2002 receipt date is one time only.  SB-BTRR 
Applications received after this date will be considered for normal SBIR 
and STTR receipt dates. NIAID expects successful applications for this 
program to be awarded within 3   5 months of receipt.  

The SB-BTRR will support SBIR and STTR applications for applied research 
targeted at the design and development of specific diagnostics, 
therapies, and prevention strategies for Category A biological diseases 
as defined by the CDC (http://www.bt.cdc.gov/Agent/Agentlist.asp), which 
includes:  Bacillus anthracis (anthrax), Clostridium botulinum toxin 
(botulism), Yersinia pestis (plague), Variola major (smallpox), 
Francisella tularensis (tularemia) and pathogens responsible for  viral 
hemorrhagic fevers.

Specifically, this notice encourages research to develop:  
o  rapid, accurate diagnostics for natural and bioengineered microbes 
and/or toxins; 
o  novel targets for effective treatments for those infected; 
o  new prevention strategies for those at risk of exposure; and
o  improved screening methodologies for potential 
antimicrobials/antitoxins

Research that builds on recent advances in genomics and proteomics of 
these organisms is especially encouraged. 
Potential applicants are encouraged to review information on the 
bioterrorism page of the NIAID Internet site. 
http://www.niaid.nih.gov/publications/bioterrorism.htm

INQUIRIES

Inquiries are strongly encouraged.  The opportunity to clarify any 
issues or questions from potential applicants are welcome.  Applicants 
are also referred to the NIAID "Advice on SBIR and STTR Applications" 
located at http://www.niaid.nih.gov/ncn/sbir/advice/default.htm
 
Direct inquires regarding scientific, technical and programmatic issues to:

Dr. Barbara Mulach
Division of Microbiology and Infectious Diseases
National Institute of Allergy and Infectious Diseases
Room 3266, MSC-7630
6700-B Rockledge Drive
Bethesda, MD  20892-7630
Telephone:  (301) 496-1884
FAX:  (301) 480-4528
Email:  [email protected]

Direct inquires regarding application format and review to:

Dr. Gregory Milman
Room 2140, MSC-7610
6700-B Rockledge Drive
Bethesda, MD  20892-7610
Telephone:  (301) 496-8666
FAX:  (301) 402-0369
Email:  [email protected]

Direct inquires regarding fiscal matters to:

Ms. Theresa Mercogliano
Grants Management Specialist
Division of Extramural Activities
National Institute of Allergy and Infectious Diseases
6700-B Rockledge Drive, Rm. 2261, MSC 7614
Bethesda, MD  20892-7614
Bethesda, MD  20817-7614 (for express/courier service)
Telephone:  (301) 402-5512
FAX:  (301) 480-3780
Email:  [email protected]
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices